P3 HEALTH PARTNERS INC (PIII)
US7444131053 - Common Stock
Taking everything into account, PIII scores 1 out of 10 in our fundamental rating. PIII was compared to 116 industry peers in the Health Care Providers & Services industry. PIII has a bad profitability rating. Also its financial health evaluation is rather negative. PIII is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year PIII has reported negative net income.
In the past year PIII has reported a negative cash flow from operations.
PIII had negative earnings in each of the past 5 years.
PIII had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
PIII has a worse Return On Assets (-7.86%) than 64.35% of its industry peers.
PIII has a Return On Equity of -45.88%. This is in the lower half of the industry: PIII underperforms 64.35% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -7.86% | ||
| ROE | -45.88% | ||
| ROIC | N/A |
ROA(3y)-14.71%
ROA(5y)-27.73%
ROE(3y)-1558.6%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
PIII has a worse Gross Margin (1.59%) than 84.35% of its industry peers.
PIII does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 1.59% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
PIII does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, PIII has more shares outstanding
PIII has a worse debt/assets ratio than last year.
2.2 Solvency
Based on the Altman-Z score of 0.27, we must say that PIII is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 0.27, PIII is not doing good in the industry: 64.35% of the companies in the same industry are doing better.
PIII has a Debt/Equity ratio of 0.82. This is a neutral value indicating PIII is somewhat dependend on debt financing.
PIII has a Debt to Equity ratio of 0.82. This is comparable to the rest of the industry: PIII outperforms 42.61% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.82 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 0.27 |
ROIC/WACCN/A
WACC7.49%
2.3 Liquidity
PIII has a Current Ratio of 0.55. This is a bad value and indicates that PIII is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.55, PIII is not doing good in the industry: 86.09% of the companies in the same industry are doing better.
PIII has a Quick Ratio of 0.55. This is a bad value and indicates that PIII is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.55, PIII is doing worse than 83.48% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.55 | ||
| Quick Ratio | 0.55 |
3. Growth
3.1 Past
PIII shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 80.07%, which is quite impressive.
The Revenue has grown by 25.48% in the past year. This is a very strong growth!
The Revenue has been growing by 70.57% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)80.07%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q27.27%
Revenue 1Y (TTM)25.48%
Revenue growth 3Y37.65%
Revenue growth 5Y70.57%
Revenue growth Q2Q28.61%
3.2 Future
The Earnings Per Share is expected to grow by 38.90% on average over the next years. This is a very strong growth
PIII is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 18.12% yearly.
EPS Next Y71.23%
EPS Next 2Y38.9%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year21.65%
Revenue Next 2Y18.12%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
PIII reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year PIII is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PIII's earnings are expected to grow with 38.90% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y38.9%
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for PIII!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
P3 HEALTH PARTNERS INC
NASDAQ:PIII (5/17/2024, 7:20:00 PM)
Premarket: 0.6 0 (-0.74%)0.6045
+0 (+0.73%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap190.96M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -7.86% | ||
| ROE | -45.88% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 1.59% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.58
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.82 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 0.55 | ||
| Quick Ratio | 0.55 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)80.07%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y71.23%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)25.48%
Revenue growth 3Y37.65%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y